Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $122.19, giving the company a market capitalization of 151.6B. It carries a P/E multiple of 18.86 and pays a dividend yield of 2.6%.
On 2026-01-15, Gilead Sciences(GILD) stock moved within a range of $122.19 to $124.57. With shares now at $122.19, the stock is trading 0.0% above its intraday low and -1.9% below the session's peak.
Trading activity shows a volume of 2.58M, compared to an average daily volume of 5.82M.
The stock's 52-week range extends from a low of $90.82 to a high of $128.70.
The stock's 52-week range extends from a low of $90.82 to a high of $128.70.
GILD News
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of cou...
If you are wondering whether Gilead Sciences at around US$124.07 is offering good value right now, this article will walk you through what the current price mig...
Gilead Sciences (GILD) is back in focus after management used the J.P. Morgan Healthcare Conference to spotlight its broad HIV portfolio, upcoming 2026 regulato...
Analyst ratings
76%
of 29 ratingsMore GILD News
The most recent trading session ended with Gilead Sciences (GILD) standing at $99.65, reflecting a +1.69% shift from the previouse trading day's closing. The st...